Fertility Implications for Women with a <em>BRCA1</em> or <em>BRCA2</em> Germline Mutation

Fertility Implications for Women with a BRCA1 or BRCA2 Germline Mutation

Fertility Implications for Women with a BRCA1 or BRCA2 Germline Mutation (#54)

Kelly-Anne Phillips ¹ , Ian Collins ¹ , Roger Milne ² , Sue Anne McLachlan ³ , Michael Friedlander ⁴ , Martha Hickey ⁵ , John Hopper ⁶ , Richard Fisher ¹ , Catharyn Stern ⁵ , Gordon Kannemeyer ⁷ , Sandra Picken ¹ , Charmaine Smith ¹ , Richard Anderson ⁸ , Thomas Kelsey ⁹

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Cancer Council Victoria, Melbourne
St Vincent's Hospital, Melbourne
Prince of Wales Hospital, Sydney
Royal Women's Hospital, Melbourne
University of Melbourne, Melbourne
Melbourne IVF, Melbourne
University of Edinburgh, Edinburgh
University of St Andrews, Fife, UK

Publish consent withheld

#COSA2015

Authors contributing to this presentation.

Phillips, K

Professor Kelly-Anne Phillips is a consultant Medical Oncologist and Head of the Peter MacCallum Cancer Centre Breast and Ovarian Cancer Risk Management Clinic. She is committed to reducing the burden of breast cancer, through advancing and translating knowledge in breast cancer genetics, prevention and treatment. Her research interests include breast cancer prevention and prevention of chemotherapy-induced menopause.

Fertility Implications for Women with a BRCA1 or BRCA2 Germline Mutation (#54)

Phillips, K

Collins, I

Milne, R

McLachlan, S

Friedlander, M

Hickey, M

Hopper, J

Fisher, R

Stern, C

Kannemeyer, G

Picken, S

Smith, C

Anderson, R

Kelsey, T

Fertility Implications for Women with a BRCA1 or BRCA2 Germline Mutation (#54)

Add notes

Phillips, K

Collins, I

Milne, R

McLachlan, S

Friedlander, M

Hickey, M

Hopper, J

Fisher, R

Stern, C

Kannemeyer, G

Picken, S

Smith, C

Anderson, R

Kelsey, T

Login